期刊文献+

SIRTl在小鼠肾缺血再灌注损伤中的作用及其对NF-κBp65-PGC-1α信号通路的影响 被引量:9

Role of SIRT1 in renal ischemia- reperfusion injury and its effect on NF- KBp65 - PGC- 1α signal pathway in mice
原文传递
导出
摘要 目的研究沉默信息调节因子2相关酶类1(SIRT1)在小鼠肾缺血再灌注(IR)损伤中的作用及其对NF-κBp65-过氧化物酶体增殖物激活受体γ辅激活因子1α(PGC-1α)信号通路的影响。方法将72只健康雄性C57BL/6小鼠按随机数字法分成4组,正常对照组(Con组,n=18)、假手术组(Sham组,n=18)、IR组(n=18)、白藜芦醇干预组(Res组,n=18),采用双侧肾蒂夹闭45min建立急性缺血性肾损伤模型,建模前每天给予2%二甲亚砜或者白藜芦醇(10mg·kg^-1·d^-1),腹腔注射7d。常规生化法检测Scr、BUN水平,分光光度法测定肾脏组织中超氧化物歧化酶(SOD)含量,HE染色法观察肾组织学改变,免疫组织化学法、Western印迹法检测肾组织SIRT1、NF.KBp65、PGC-101的表达。结果于再灌注12h开始,IR组血清Scr和BUN高于Con组和Sham组(均P〈0.05),Res组上述指标低于同期IR组(均P〈0.05);IR组肾组织SOD水平低于Con组和Sham组(均P〈0.05),至24h时Res组SOD水平高于IR组(P〈0.05)。HE染色显示,IR组肾脏存在不同程度的肾小管上皮细胞坏死等病理损害,而Res组病理损伤减轻。Western印迹结果显示肾脏缺血再灌注后SIRT1的表达升高,NF-κB信号通路被激活,p65的表达升高,PGC-1α的表达降低,与Con组和Sham组相比差异均有统计学意义(均P〈0.05)。Western印迹和免疫组化结果均显示,再灌注24h后,Res组SIRTl、PGC-1α的表达高于IR组(均P〈0.05),而Res组NF-κBp65的表达低于IR组(P〈0.05)。结论在小鼠肾缺血再灌注模型中,激动SIRT1可以抑制NF-κBp65的表达,从而上调PGC-1α水平,减轻炎性反应和氧化应激损伤,对肾脏起到保护作用。 Objective To investigate the role of silent mating type information regulation 2 homologue 1(SIRT1) in renal ischemia-reperfusion(IR) injury and its effect on NF-KBp65 - peroxisome proliferator-activated receptor gamma eoactivator 1 alpha (PGC-1α) signal pathway in mice. Methods Seventy- two healthy C57BL/6 male mice were randomly divided into four groups: control group(n= 18), sham-operated group(n=18), IR group(n=18), resveratrel group(n=18). Bilateral renal pedicle were clamped for 45 min was adopted to establish the model of acute ischemic renal injury, to give 2% dimethyl sulfoxide or resveratrol by intraperitoneal injection for 7 days before modeling. Determination techniques included routine biochemical methods for the the levels of Scr and BUN, spectrophotometryfor the level of superoxide dismutase (SOD), HE staining for the histological changes as well as immunohistochemical method and Western blotting for the expressions of SIRT1, NF-κBp65 and PGC- 1α, respectively. Results Compared with that in control and sham-operated groups, the levels of serum Scr and BUN were higher and SOD levels in renal tissues were lower at 12 h and 24 h after operation in IR groups(P 〈 0.05). liE staining revealed evident pathological lesions including necrosis of renal tubular epithelial cells in IR group. Compared with that in IR group, resveratrol attenuated the abovementioned changes. Western blotting revealed the upregulated SIRT1 expression and the activated NF-κB signal pathway, the up-regulated p65 expression and the down-regulated PGC-let expression subsequent to IR(P 〈 0.05). Both Western blotting and immunohistochemistry showed that the expressions of SIRT1 and PGC-let in resveratrol group were up-regulated compared to that in IR group(P 〈 0.05), while the NF- KBp65 expression in resveratrol group was down- regulated(P 〈 0.05). Conclusions In mouse model of renal ischemia- reperfusion injury, the activation of SIRT1 can inhibit the NF- κBp65 expression and accordingly upregulated PGC- 1α level, contributing to inhibiting inflammatory reactions and attenuating oxidative stressinduced injury in the protection of the kidneys.
出处 《中华肾脏病杂志》 CAS CSCD 北大核心 2015年第2期133-139,共7页 Chinese Journal of Nephrology
关键词 再灌注损伤 氧化性应激 炎症 SIRT1 白藜芦醇 Reperfusion injury Oxidative stress Inflammation SIRT1 Resveratrol
  • 相关文献

参考文献19

  • 1Macedo E, Bouchard J, Mehta RL. Renal recovery following acute kidney injury[J]. Curr Opin Crit Care, 2008, 14(6): 660- 665.
  • 2Sharfuddin AA, Molitoris BA. Pathophysiology of ischemic acute kidney injury[J]. Nat Rev Nephrol, 2011, 7(4): 189-200.
  • 3Kucuk A, Kabadere S, Tosun M, et al. Protective effects of doxycycline in ischemia/reperfusion injury on kidney[J]. J Physiol Biochem, 2009, 65(2): 183-191.
  • 4Fan H, Yang HC, You L, et al. The histone deacetylase, SIRT1, contributes to the resistance of young mice to ischemia/ reperfusion-induced acute kidney injury[J]. Kidney Int, 2013, 83(3): 404-413.
  • 5Tang BL. Sirtl's systemic protective roles and its promise as a target in antiaging medicine[J]. Transl Res, 2011, 157(5): 276- 284.
  • 6Hao CM, Haase VH. Sirtuins and their relevance to the kidney [J}. J Am Soc Nephrol, 2010, 21(10): 1620-1627.
  • 7Wan X, Yang J, Xing L, et al. Inhibition of ikappab kinase beta attenuates hypoxia-induced inflammatory mediators in rat renal tubular cells[J]. Transplant Proc, 2011, 43(5): 1503-1510.
  • 8Wan X, Fan L, Hu B, et al. Small interfering RNA targeting IKKI3 prevents renal ischemia-reperfusion injury in rats[J]. Am J Physiol Renal Physiol, 2011,300(4): F857-F863.
  • 9Puigserver P, Spiegelman BM. Peroxisome prohferator- activated receptor-gamma coactivator 1 alpha (PGC- 1 alpha): transcriptional coactivator and metabolic regulator[J]. Endocr Rev, 2003, 24(1): 78-90.
  • 10Feingold K, Kim MS, Shigenaga J, et al. Altered expression of nuclear hormone receptors and coactivators in mouse heart during the acute- phase response[J]. Am J Physiol Endocrinol Metab, 2004, 286(2): E201-E207.

二级参考文献55

  • 1Ruan XZ, Varghese Z, Powis SH, et al. Nuclear receptors and their coregulators in kidney. Kidney Int, 2005, 68: 2444 - 2461.
  • 2Han SJ, Jung SY, Malovannaya A, et al. A scoring system for the follow up study of nuclear receptor coactivator complexes. Nucl Recept Signal, 2006, 4: e014.
  • 3Xu J, Li Q. Review of the in vivo functions of the p160 steroid receptor coactivator family. Mol Endocrinol, 2003, 17: 1681-1692.
  • 4Cernuda-Morollon E, Rodriguez-Pascual F, Klatt P, et al. PPAR agonists amplify iNOS expression while inhibiting NF kappaB: implications for mesangial cell activation by cytokines. J Am Soc Nephrol, 2002, 13: 2223-2231.
  • 5Panzer U, Steinmetz OM, Stahl RA, et al. Kidney diseases and chemokines. Curr Drug Targets, 2006, 7: 65-80.
  • 6Luster AD. Chemokines chemotactic eytokines that mediate inflammation. N Engl J Med, 1998, 338: 436-445.
  • 7Segerer S, Nelson P J, Schlondorff D. Chemokines, chemokine receptors, and renal disease: from basic science to pathophysiologic and therapeutic studies. J Am Soc Nephrol, 2000, 11: 152-176.
  • 8Daha MR, van Kooten C. Is the proximal tubular cell a proinflammatory cell? Nephrol Dial Transplant, 2000, 15 Suppl 6: 41-43.
  • 9Qi w, Chen X, Polhill TS, et al. TGF-beta1 induces IL-8 and MCP- 1 through a connective tissue growth factor independent pathway. Am J Physiol Renal Physiol, 2006, 290: F703-F709.
  • 10Qi w, Chen X, Holian J, et al. Transforming growth factor-betal differentially mediates fibronectin and inflammatory cytokine expression in kidney tubular cells. Am J Physiol Renal Physiol, 2006, 291: F1070-F1077.

共引文献3

同被引文献42

  • 1赵静姝,王蓉.沉默信息调节因子2同源体1及其激动剂的神经生物学作用[J].医学研究生学报,2011,24(12):1324-1328. 被引量:2
  • 2Na Zhang,Gen-Yang Cheng,Xian-Zhi Liu,Feng-Jiang Zhang.Expression of Bcl-2 and NF-κB in brain tissue after acute renal ischemia-reperfusion in rats[J].Asian Pacific Journal of Tropical Medicine,2014,7(5):386-389. 被引量:11
  • 3Widgerow AD. lschemia- reperfusion injury: influencing the microcirculatory and cellular environment[J]. Ann Plast Surg, 2014, 72(2): 253-260.
  • 4Kusch A, Hoff U, Bubalo G, et al. Novel signalling mechanisms and targets in renal ischaemia and reperfusion injury[J]. Acta Physiol (Oxf), 2013, 208(1): 25- 40.
  • 5McDonald C, Chen FF, Ollendorff V, et al. A role for Erbin in the regulation of Nod2- dependent NF- kappaB signaling[J]. J Biol Chem, 2005, 280(48): 40301- 40309.
  • 6Li J, Gong Q, Zhong S, et al. Neutralization of the extracellular HMGB1 released by ischaemic damaged renal cells protects against renal ischaemia- reperfusion injury[J]. Nephrol Dial Transplant, 2011, 26(2): 469-478.
  • 7Melnikov VY, Faubel S, Siegmund B, et al. Neutrophil- independent mechanisms of caspase- 1 - and IL- 18 -mediated ischemic acute tubular necrosis in mice[J]. J Clin Invest, 2002, 110(8): 1083-1091.
  • 8Kumar S, Allen DA, Kieswich JE, et al. Dexamethasone ameliorates renal ischemia- reperfusion injury[J]. J Am Soc Nephrol, 2009, 20(11): 2412- 2425.
  • 9Korkmaz A, Ko|ankaya D. Inhibiting inducible nitric oxide synthase with rutin reduces renal ischemia/reperfusion injury [J]. Can J Surg, 2013, 56(1): 6-14.
  • 10Di PR, Genovese T, Impellizzeri D, et al. The renal injury and inflammation caused by ischemia- reperfusion are reduced by genetic inhibition of TNF-etRI: a comparison with infliximab treatment[J]. Eur J Pharmacol, 2013, 700(1-3): 134-146.

引证文献9

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部